Real-time enrollment status for this non-obstructive hypertrophic cardiomyopathy clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:47 AM UTC
| NCT Number | NCT07023614 |
| Recruiting Status | Recruiting |
| Condition | Non-obstructive Hypertrophic Cardiomyopathy |
| Phase | PHASE2 |
| Target Enrollment | 165 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Imbria Pharmaceuticals, Inc. |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of August 28, 2026: Clinical trial NCT07023614 is currently recruiting participants. This phase2 study for non-obstructive hypertrophic cardiomyopathy is actively seeking new participants at 22 locations across the United States. The study is sponsored by Imbria Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07023614 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07023614 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.